Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination "adrenaline + noradrenaline + dopamine + dobutamine" refers to four distinct sympathomimetic medications that are commonly used in critical care settings for cardiovascular support. These drugs are not typically administered as a single formulation but are used individually or in specific combinations based on clinical needs. ## Individual Components **Adrenaline (Epinephrine)** Adrenaline is a potent nonselective adrenergic agonist that stimulates both α and β receptors. It increases heart rate, contractility, and causes vasoconstriction, leading to increased blood pressure[1][3]. It's commonly used in cardiac arrest, anaphylaxis, and shock states. **Noradrenaline (Norepinephrine)** Norepinephrine primarily stimulates α-receptors causing vasoconstriction, with some β1 activity that increases cardiac contractility[2][6]. It's considered a first-line vasopressor in septic shock and other hypotensive states[6][8]. **Dopamine** Dopamine has dose-dependent effects: at low doses (1-4 μg/kg/min) it primarily affects dopaminergic receptors increasing renal and mesenteric blood flow; at intermediate doses (4-10 μg/kg/min) it has significant β1 effects increasing cardiac output; at higher doses (>10 μg/kg/min) it has α-adrenergic effects causing vasoconstriction[5][6]. **Dobutamine** Dobutamine is predominantly a β1-agonist that increases cardiac contractility with minimal effect on heart rate[2][6]. It's the first-line inotropic agent for cardiogenic shock and heart failure with low cardiac output[6]. ## Clinical Applications of Combinations These medications are sometimes used in combination for specific clinical scenarios: 1. **Norepinephrine + Dobutamine**: This is a common combination in septic shock when patients need both vasopressor support (norepinephrine) and inotropic support (dobutamine)[4][6]. Dobutamine helps improve cardiac output while norepinephrine maintains blood pressure. 2. **Norepinephrine + Epinephrine**: This combination has been studied in septic shock, showing positive effects on cardiovascular parameters but potentially negative effects on serum lactate and pH compared to norepinephrine plus dobutamine[4]. 3. **Multiple Agent Combinations**: In complex shock states, particularly post-cardiac surgery, combinations of three or more agents may be used (e.g., epinephrine + norepinephrine + dobutamine)[8]. Each drug has distinct receptor affinities and hemodynamic effects, allowing clinicians to tailor therapy to specific patient needs. The choice of agent(s) depends on the underlying pathophysiology, hemodynamic goals, and patient response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adrenaline, Noradrenaline, Dopamine, and Dobutamine Combination.